Skip to main content

Saturn Medic

Clinical Subject Page

Acute Diarrheal Disease

Acute Diarrheal Disease is characterized by the sudden onset of loose or watery stools, usually lasting less than 14 days. It is commonly caused by gastrointestinal infections, especially viruses and bacteria. The main immediate concern is dehydration and electrolyte loss, while severe cases may cause hypovolemic shock, Acute Kidney Injury (AKI), or sepsis

Also called

Acute diarrhea

ICD-10

R19.7

Specialty

Infectious

Onset

Acute

Reviewed

August 2026
On This Page

Overview

Acute Diarrheal Disease may be infectious or non-infectious. Infectious causes include viruses, bacteria, and parasites, while non-infectious causes include medications, toxins, food intolerance, and other gastrointestinal disorders.

Common infectious causes include norovirus, rotavirus, Escherichia coli, Salmonella, Shigella, Campylobacter, and Vibrio cholerae

Etiology & Risk Factors

Acute Diarrhoeal Disease · Aetiology & Risk Factors

Definition
WHO criteria
≥3 loose/watery stools per day. Duration <14 days = acute. 14–30 days = persistent. >30 days = chronic.
Secretory
Toxin-mediated
Watery, large volume. Persists with fasting. Osmotic gap normal. Cholera, ETEC, S. aureus toxin.
Osmotic
Malabsorption
Stops with fasting. High osmotic gap. Giardia, lactose intolerance, laxative use, rotavirus.
Inflammatory
Invasive / Dysentery
Bloody mucoid stool. Fever. Small volume + tenesmus. Shigella, Campylobacter, STEC, Salmonella.
Aetiology — by Category
CategoryPathogensTypical clinical clueCommon source
Bacterial
Most common cause of acute ADD worldwide
Non-invasive / toxigenic: ETEC, V. cholerae, S. aureus, B. cereus, C. perfringens
Invasive: Shigella, Salmonella, Campylobacter, STEC O157, EIEC, Yersinia enterocolitica, C. difficile
Fever + bloody diarrhoea = invasive. No fever + watery = toxigenic. STEC: bloody, no fever → HUS. Contaminated food, water, person-to-person (Shigella), poultry (Campylobacter), beef (STEC)
Viral
Most common in children <5
Rotavirus (children — leading cause globally), Norovirus (all ages — most common overall), Adenovirus (types 40/41), Astrovirus, Sapovirus Vomiting prominent, watery diarrhoea, low fever. Winter season (Norovirus). Age <5 years (Rotavirus). Person-to-person, contaminated water, shellfish (Norovirus), faecal-oral
Parasitic
Subacute / travel-related
Giardia lamblia, Cryptosporidium parvum, Entamoeba histolytica (amoebic dysentery), Cyclospora cayetanensis, Isospora belli Giardia: fatty floating stools. Entamoeba: bloody + mucus, travel history. Cryptosporidium: severe in HIV. Contaminated water (Giardia, Cryptosporidium), travel to endemic areas (Entamoeba)
Non-infectious Medications (antibiotics, laxatives, metformin, NSAIDs, proton pump inhibitors), IBD flare, ischaemic colitis, food allergy, toxins (mushroom, heavy metals), radiation colitis No infectious contact; drug history; chronic IBD background; recent radiation therapy. Drug history, underlying disease, toxic ingestion
Aetiology by Setting — Exam-Focused
SettingMost likely pathogensKey clue
Community / sporadic Norovirus, Rotavirus (children), Campylobacter, Salmonella, ETEC Most cases — no specific risk factor; faecal-oral spread
Foodborne outbreak
≥2 people, same food
<6h: S. aureus / B. cereus. 8–16h: C. perfringens. >12h: Salmonella, Campylobacter, Norovirus Incubation period + food source narrows it immediately
Traveller's diarrhoea
Travel to developing country
ETEC (#1 cause — 40–70%), Shigella, Salmonella, Campylobacter, Entamoeba, Giardia, Norovirus, Cyclospora ETEC: watery, no blood. Shigella/Campylobacter: bloody + fever. Giardia: weeks later, fatty stools.
Healthcare-associated / antibiotic use Clostridioides difficile — most important nosocomial cause Recent antibiotics (especially clindamycin, cephalosporins, fluoroquinolones, amoxicillin). Hospital admission. Watery diarrhoea, fever, raised WBC.
Immunocompromised / HIV Cryptosporidium, Microsporidium, Isospora, CMV colitis, MAC, Salmonella (recurrent) CD4 count determines likely pathogen. Cryptosporidium + CD4 <200 = life-threatening chronic diarrhoea.
Day care / institutional Rotavirus (children), Shigella, Giardia, Cryptosporidium, Norovirus Children age <5. Close contact. Water play. Poor hand hygiene.
Seafood / shellfish Norovirus, Vibrio parahaemolyticus, Vibrio vulnificus, Hepatitis A Raw oysters → Norovirus. Vibrio: coastal areas, septicaemia in liver disease.
Risk Factors
Host risk factors
Age extremes — infants (immature immunity), elderly (↓ gastric acid, immunosenescence)
Immunocompromised — HIV, chemotherapy, steroids, transplant
↓ Gastric acid — PPI use, achlorhydria, gastrectomy → reduced barrier to infection
Antibiotic use — disrupts gut flora → C. difficile, overgrowth of pathogens
Malnutrition — impaired immunity, gut barrier dysfunction
Inflammatory bowel disease — susceptibility to superimposed infection
Pregnancy — Listeria, Salmonella carry higher risk of complications
Environmental / exposure risk factors
Contaminated water — untreated, well water, flooding (cholera, Giardia, Cryptosporidium)
Unsafe food handling — inadequate cooking, cross-contamination, improper storage
Travel to endemic areas — ETEC, Shigella, Entamoeba, Typhoid
Animal contact — reptiles (Salmonella), farm animals, petting zoos (STEC, Campylobacter)
Hospitalisation — C. difficile, nosocomial spread, antibiotic exposure
Crowded settings — refugee camps, prisons, cruise ships, military (Norovirus, Shigella)
Swimming pools / recreational water — Cryptosporidium (chlorine-resistant)
Factors increasing severity
Age <5 or >65 — rapid dehydration, mortality risk
Underlying renal disease — worsened by dehydration + STEC
Sickle cell disease — Salmonella bacteraemia + osteomyelitis
Delayed presentation — severe dehydration, electrolyte crisis
Inappropriate antibiotics — STEC → HUS; Salmonella → prolonged carriage
Loperamide misuse — toxic megacolon in Shigella/C. difficile
Lack of access to ORS — avoidable deaths, especially in children
Global burden: Acute diarrhoeal disease causes ~1.7 billion episodes/year globally. Second leading cause of death in children <5 years (after pneumonia). 90% of deaths occur in developing countries — largely preventable with safe water, ORS, and vaccines (Rotavirus, cholera, Typhoid). Malnutrition + diarrhoea = vicious cycle — each worsens the other.

Pathophysiology

Pathogen or toxin ingestion → intestinal infection or epithelial injury → altered secretion and absorption of water and electrolytes → increased stool water content → diarrhea → fluid and electrolyte lossdehydration ± systemic complications

Clinical Presentation

-Symptoms:

Acute Diarrheal Disease commonly causes:

  • Frequent loose or watery stools
  • Abdominal cramps
  • Nausea
  • Vomiting
  • Fever
  • Malaise

Other features may include:

  • Urgency
  • Tenesmus
  • Blood or mucus in stool
  • Headache

 

-Signs:

  • Dry mucous membranes
  • Increased thirst
  • Tachycardia
  • Reduced urine output
  • Orthostatic hypotension
  • Abdominal tenderness
  • Fever

 

-Severe Disease

Severe Acute Diarrheal Disease may cause:

  • Severe dehydration
  • Hypovolemic shock
  • Electrolyte abnormalities
  • Acute Kidney Injury (AKI)
  • Sepsis
  • Altered mental status
Acute Diarrheal Disease Overview
Thromboangiitis Obliterans (TAO) Overview

History Taking

-Ask about:

  • Onset and duration of diarrhea
  • Stool frequency and volume
  • Watery versus bloody stool
  • Fever and chills
  • Abdominal pain
  • Vomiting
  • Fluid intake and urine output
  • Recent food or water exposure
  • Recent travel
  • Sick contacts
  • Recent antibiotic use

Physical Examination

-General Examination

  • Temperature
  • Heart rate and blood pressure
  • Hydration status
  • Mental status
  • Signs of shock

 

-System-Specific Examination:

  • Abdominal tenderness
  • Abdominal distension
  • Bowel sounds
  • Guarding or peritonism when severe abdominal pathology is suspected

Investigations

-Biochemistry / Specific Tests

  • Serum electrolytes and renal function in significant dehydration

  • Stool culture or molecular testing in selected patients

  • Blood cultures when bacteremia or sepsis is suspected

  • Stool testing for specific pathogens when clinically indicated

 

-Imaging

Not routinely required.

Imaging may be appropriate when there is severe abdominal pain, suspected complications, or concern for an alternative diagnosis.

 

-Special / Confirmatory Tests

Stool testing should be considered with:

  • Bloody diarrhea

  • High fever

  • Severe illness

  • Persistent diarrhea

  • Suspected outbreak

  • Significant immunosuppression

Diagnosis

-Acute Diarrheal Disease is usually diagnosed clinically:

Acute onset of loose stools → assess hydration, stool characteristics, exposure history, and red flags → perform stool testing when indicated.

Management

Acute Diarrhoeal Disease · Assessment & Rehydration

No Dehydration
Fluid loss <5%
  • Alert, drinking normally
  • Normal skin turgor, eyes, mucosa
  • Normal urine output
  • No sunken fontanelle
  • Plan A — ORS at home
Some Dehydration
Fluid loss 5–10%
  • Restless, irritable, thirsty
  • Sunken eyes, dry mouth
  • Skin pinch returns slowly (>2 sec)
  • Decreased urine output
  • Plan B — ORS in clinic 4h
Severe Dehydration
Fluid loss >10%
  • Lethargic, unconscious
  • Very sunken eyes, no tears
  • Skin pinch returns very slowly (>3 sec)
  • Unable to drink / drinks poorly
  • Plan C — IV fluids urgently
Initial Assessment
History — key questions
Duration, frequency, volume of stools
Blood or mucus in stool — suggests invasive pathogen
Fever — temperature, duration
Vomiting — ability to take oral fluids
Recent food / water exposure, travel, antibiotic use
Contact with ill persons, animal exposure
Urine output — last void, colour
Examination
Vital signs — HR, BP, temp, RR
Capillary refill — >2 sec = poor perfusion
Skin turgor — pinch abdomen / back of hand
Mucous membranes + eyes — dryness
Fontanelle — sunken in infants
Abdomen — tenderness, distension, bowel sounds
Weight — compare to recent if possible
Red flags — admit immediately
Severe dehydration — lethargy, unable to drink
Bloody diarrhoea + high fever + systemic toxicity
Age <6 months or elderly with significant dehydration
Persistent vomiting — unable to maintain ORS
Signs of HUS — oliguria + pallor + petechiae after bloody diarrhoea
Immunocompromised, pregnancy, sickle cell
Abdominal rigidity / peritonitis signs
Rehydration — WHO Plans A / B / C
WHO PlanDehydrationFluidDose & MethodKey points
Plan A None ORS — WHO low-osmolarity formula (75 mEq Na, 75 mmol glucose, 20 mEq K) <2 yrs: 50–100 mL after each stool. 2–10 yrs: 100–200 mL after each stool. >10 yrs: as much as wanted. Continue feeding. Home treatment. Return if worsening, blood in stool, not drinking.
Plan B Some (5–10%) ORS — supervised in clinic/hospital 75 mL/kg over 4 hours. Reassess every hour. If vomiting — small frequent sips (5 mL every 2–3 min). Continue breastfeeding throughout. Reassess after 4h. If improved → Plan A. If worse → Plan C. Avoid juice/carbonated drinks.
Plan C Severe (>10%) IV Ringer's lactate — preferred. Normal saline if RL unavailable. Infants <12 months: 30 mL/kg over 1h, then 70 mL/kg over 5h.
Children >1yr / adults: 30 mL/kg over 30 min, then 70 mL/kg over 2.5h.
Reassess every 15–30 min.
ICU/HDU. Monitor urine output. Electrolytes. Switch to ORS as soon as able to drink.
ORS composition (WHO low-osmolarity): Glucose 75 mmol/L + Na⁺ 75 mEq/L + K⁺ 20 mEq/L + Cl⁻ 65 mEq/L + Citrate 10 mmol/L = osmolarity 245 mOsm/L. Lower osmolarity reduces vomiting + stool output vs original formula. Rice-based ORS equally effective. Zinc supplementation 10–20 mg/day × 10–14 days — reduces duration + severity in children <5 (WHO recommendation).

Acute Diarrhoeal Disease · Antibiotic & Specific Treatment

Antibiotic Treatment — When & What
Pathogen / ConditionAntibioticWhen to treatAvoid / Notes
Empirical — traveller's diarrhoea
Watery, no blood, no fever
Azithromycin 1g single dose PO — preferred globally (low resistance)
Ciprofloxacin 500 mg BD × 1–3 days — if azithromycin unavailable
Rifaximin 200 mg TDS × 3 days — non-invasive, non-febrile only
Moderate–severe traveller's diarrhoea. Mild → supportive only. Rifaximin: not for bloody/febrile diarrhoea
Shigella (dysentery) Azithromycin 500 mg OD × 3 days — 1st line
Ciprofloxacin 500 mg BD × 3 days — if sensitive
Ceftriaxone 2g IV OD — severe / MDR
Always treat — reduces severity, duration, transmission No loperamide — toxic megacolon risk
Campylobacter Azithromycin 500 mg OD × 3 days — preferred (↑ fluoroquinolone resistance)
Ciprofloxacin — only if sensitivity confirmed
Severe / prolonged (>7 days), immunocompromised, bacteraemia. Early treatment if within 3 days. No benefit if started late (>3 days)
Salmonella NTS Ciprofloxacin 500 mg BD PO or 400 mg IV BD
Ceftriaxone 2g IV OD — fluoroquinolone resistant
Only if high-risk: age <1 or >65, immunocompromised, SCD, asplenia, bacteraemia Routine cases: no antibiotics — prolong carriage
No loperamide
E. coli O157 (STEC) CONTRAINDICATED — all antibiotics increase Shiga toxin → HUS risk
Supportive only: IV fluids, avoid NSAIDs, monitor renal function
Never — antibiotics worsen outcome No antibiotics
No loperamide
No NSAIDs
C. difficile Mild–moderate: Metronidazole 400 mg TDS PO × 10 days (resource-limited)
Moderate–severe: Vancomycin 125 mg QDS PO × 10 days — preferred
Recurrent: Fidaxomicin 200 mg BD × 10 days — lower recurrence rate
Always treat. Stop precipitating antibiotic if possible. Isolate patient. No loperamide — toxic megacolon. Oral vancomycin not absorbed — acts locally in colon.
Cholera Doxycycline 300 mg single dose — adults 1st line
Azithromycin 1g single dose — children + pregnancy
Ciprofloxacin 1g single dose — alternative
Moderate–severe cholera. ORS is cornerstone — antibiotics adjunct only. ORS priority — antibiotics reduce duration 50% but hydration saves lives
Giardia Metronidazole 400 mg TDS × 5–7 days
Tinidazole 2g single dose — preferred (better compliance)
Always treat symptomatic infection Avoid alcohol with metronidazole
Entamoeba histolytica
Amoebic dysentery
Metronidazole 800 mg TDS × 5 days (tissue amoebiasis)
Followed by: Diloxanide furoate 500 mg TDS × 10 days — luminal agent to clear cysts
Always treat. Need both agents — metronidazole alone misses luminal cysts → relapse. Must complete luminal agent or relapse common
Cryptosporidium Immunocompetent: supportive — self-limiting
HIV/immunocompromised: Nitazoxanide 500 mg BD × 3 days + ART — CD4 recovery is key
Always treat in immunocompromised. No treatment in healthy patients. ART (HIV) = most effective treatment — CD4 recovery clears infection
Antibiotic rules to memorise: Most acute diarrhoea = supportive only. Shigella — always treat. STEC — never treat with antibiotics. C. difficile — oral vancomycin preferred (metronidazole only if resource-limited). Amoeba — metronidazole + luminal agent (diloxanide). Campylobacter — azithromycin (fluoroquinolone resistance rising globally).
Adjunct & Supportive Measures
Medications
Ondansetron 4–8 mg PO/IV — antiemetic; allows ORS to be taken
Zinc 10–20 mg/day × 10–14 days — children <5 (WHO); reduces duration + future episodes
Loperamide — watery non-bloody, non-febrile only. Adult traveller's diarrhoea. Never in children <2, never in bloody/febrile diarrhoea.
Paracetamol — fever + cramping. Avoid NSAIDs (worsen GI mucosa + STEC outcome).
Probiotics — limited evidence; may shorten viral diarrhoea duration by 1 day
Nutrition
Continue feeding — early re-feeding shortens illness; prevents malnutrition
Continue breastfeeding — breast milk protective; do not stop during diarrhoea
Age-appropriate foods — rice, bread, banana, cooked vegetables. Avoid high-fat, high-sugar.
Avoid fasting — BRAT diet (Banana, Rice, Applesauce, Toast) — acceptable but not superior to normal diet
Avoid fruit juices + carbonated drinks — high osmolarity worsens osmotic diarrhoea
Infection control
Hand hygiene — soap + water (alcohol gel ineffective against Norovirus, C. difficile spores)
Isolate hospitalised patients — single room. Contact precautions.
Notify public health — Shigella, Cholera, Typhoid, STEC O157, C. difficile outbreaks
Exclude from food handling/childcare — Norovirus, Shigella, Salmonella until symptom-free 48h
Stool cultures — bloody diarrhoea, systemically unwell, travel, immunocompromised, outbreaks

Complications

  • Severe dehydration
  • Electrolyte disturbances
  • Hypovolemic shock
  • Acute Kidney Injury (AKI)
  • Sepsis
  • Hemolytic Uremic Syndrome (HUS)
  • Reactive arthritis
  • Malnutrition
  • Death in severe untreated disease

Prognosis

The prognosis of Acute Diarrheal Disease is generally excellent, with most uncomplicated infections resolving within several days. Prognosis is less favorable in infants, older adults, immunocompromised patients, and those with severe dehydration or invasive infection.

Key Points / Clinical Pearls

  • Acute diarrhea usually lasts less than 14 days.
  • Most cases are infectious.
  • Viruses are common causes of acute gastroenteritis.
  • Bloody diarrhea suggests inflammatory or invasive disease.
  • Dehydration is the most important immediate complication.
  • Oral rehydration is the main treatment for most patients.
  • IV fluids are required for severe dehydration or shock.
  • Stool testing is reserved for selected severe, persistent, bloody, or outbreak-associated cases.
  • Antibiotics are not routinely required for uncomplicated infectious diarrhea.
  • Antimotility drugs should be avoided with bloody diarrhea or high fever.
  • Severe disease can cause Acute Kidney Injury (AKI).
  • World Health Organization (WHO). Diarrhoeal Disease .
  • Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis. 2017;65(12):e45-e80. PubMed .
  • Riddle MS, DuPont HL, Connor BA. ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. Am J Gastroenterol. 2016;111(5):602-622. PubMed .
  • DuPont HL. Acute Infectious Diarrhea in Immunocompetent Adults. N Engl J Med. 2014;370(16):1532-1540. New England Journal of Medicine .
  • Guarino A, Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe. J Pediatr Gastroenterol Nutr. 2014;59(1):132-152. PubMed .
  • King CK, Glass R, Bresee JS, Duggan C. Managing Acute Gastroenteritis Among Children: Oral Rehydration, Maintenance, and Nutritional Therapy. MMWR Recomm Rep. 2003;52(RR-16):1-16. CDC .
  • National Library of Medicine (NIH). Acute Diarrhea . StatPearls.